Serum eosinophil cationic protein as a predictor of disease activity in acute and chronic asthma

East African Medical Journal

Volumn 76, Issue 9, 1999, Pages 524-529

  Onadeko, B O ^a   Khadadah, M E ^b   Mustafa, H T S ^b   Ezeamuzie, C I ^b   Marouf, R ^b   Khamis, A ^b   Sugathan, T N ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; EOSINOPHIL GRANULE PROTEIN; PLASMA PROTEIN; RIBONUCLEASE;

ACUTE DISEASE; ADOLESCENT; ADULT; ARTICLE; ASTHMA; BLOOD; CASE CONTROL STUDY; CHRONIC DISEASE; EOSINOPHIL; FEMALE; HUMAN; IMMUNOLOGY; LEUKOCYTE COUNT; MALE; METABOLISM; MIDDLE AGED; PEAK EXPIRATORY FLOW; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; REPRODUCIBILITY;

ACUTE DISEASE; ADOLESCENT; ADULT; ASTHMA; BIOLOGICAL MARKERS; BLOOD PROTEINS; CASE-CONTROL STUDIES; CHRONIC DISEASE; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RIBONUCLEASES;

EID: 0033183038     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Horn, B.R. Robin, E.D., Theodore, J. and Vankessel, A. Total eosinophil counts in the management of bronchial asthma. N. Engl. J. Med. 1975; 292: 1152-1155.
2. Durham, S.R., Loegering, D.A., Dunnette, S., Gleich, G.J. and Kay, A.B. Blood eosinophils and eosinophil derived proteins in allergic asthma. J. Allergy Clin. Immunol. 1989; 84: 931-936.
3. Frigas, E. and Gleich, G.J. The eosinophil and the pathophysiology of asthma. J. Allergy Clin. Immunol. 1986, 77: 527-537.
4. Janson C. and Herala M. Blood eosinophil count as a risk factor for relapse in acute asthma. Resp. Med. 1992; 86: 101-104.
5. Fujisawa, T., Terada, A., Atsuta, J., Iquchi, K., et al. Clinical utility of serum levels of eosinophil calionic protein for monitoring and predicting clinical course in childhood asthma. Clin. Exp. Allergy. 1998; 28: 19-25.
6. Venge, P. and Dahl, R. Are blood eosinophil number and activity important for the development of the late asthmatic reaction after allergen challenge? Eur. Respir. J. 1989; 2: 4305-4345.
7. Ellis, A.G. The pathological anatomy of bronchial asthma. Amer. J. Med. Sci. 1908; 36: 407.
8. Gleich, G.J. The eosinophil and bronchial asthma. Current understanding. J. Allergy Clin. Immunol. 1990; 85: 422-436.
9. Bousquet, J. Chanez, P., Lacoste, J.Y., Barneon, G., Gharman, N., et al. Eosinophilic inflammation in asthma. New Engl. J. Med. 1990; 323: 1033-1039.
10. Motojima, S., Frigas, E., Loegering, D.A. and Gleich, G.J. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Amer. Rev. Respir. Dis. 1989; 139: 801-805.
11. Bruijnzeal, D.C.B. Contribution of eosinophil derived mediators in asthma. Int. Arch. Allergy. Appl. Immunol. 1989; 90: 57-63.
12. Venge, P. and Hakansson, L. Current understanding of the role of the eosinophil granulocyte in asthma. Clin. Exp. Allergy. 1991; 21: 31-37.
13. Kuehr, J., Frischer, T., Barth, R., Karmans. W., Kruger, S., et al. Eosinophils and eosinophilic cationic protein in children with and without sensitization to inhaled allergens. Eur. J. Paediat. 1994; 153: 739-744.
14. Venge, P., Hakansson, L. and Peterson, C.G.B. Eosinophil activation in allergic diseases. Int. Arch. Allergy Appl. Immunol. 1987; 82: 333-337.
15. Venge, P. Dahl, R., Fredens, K. and Peterson, C.G.B. Epithelial injury by human eosinophils. Amer. Rev. Respir. Dis. 1988; 138: 54-57.
16. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease and asthma. Amer. Rev. Respir. Dis. 1987; 136: 225-244.
17. Venge, P, Dahl, R., Fredens, K., Hallgren, R. and Peterson, C. Eosinophil cationic proteins in health and disease. In Yoshida T; Torisumeds. Immunology of the eosinophil. New York, Elsevier; 1983: 163-179.
18. Hallgren, R. and Venge, P. The eosinophil in inflammation. In Matson P., Ahlsted S., Venge P, Thorell J., ads. Clinical impact of allergic inflammation. London: Academic Press. 1991: 119-140.
19. Zimmerman, B., Lanner, A., Enander, I., Zimmerman, R.S., Peterson, C.G.B. and Ahlstedt, S. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy. Clin. Exp. Allergy. 1993; 23: 564-570.
20. Robinson, D.S., Assoufi, B., Durham, S.R. and Kay, A.B. Eosinophil cationic protein and eosinophil protein X concentrations in serum and bronchial lavage fluid in asthma. Effect of prednisolone treatment. Clin. Exp. Allergy. 1995; 25: 1118-1127
21. Koller, D.Y., Gotz, M., Hagel, E., Urbanek, R. and Eichler, J. Clinical value of monitoring eosinophil activity in asthma. Arch. Dis. Child. 1995; 73: 413-417.
22. Ferguson, A.C. and Wong, F.W.M. Bronchial hyperresponsiveness in asthmatic children. Correlation with macrophages and eosinophils in bronchial lavage fluid. Chest 1989; 96: 988-991.
23. Juntunen-Backrnan, K., Jarvinem, P. and Sorva, R. Serum eosinophil cationic protein during treatment of asthma in children. J. Allergy Clin. Immunol. 1993; 92: 34-38.